Developer docs
API playgroundTry for free, no card

Search company profiles

MIG Fonds

Full company profile

uuid000deb2

Namestring
MIG Fonds
Legal namestring
MIG Beteiligungstreuhand GmbH
Websiteurl
mig-fonds.de
Company typeenum
Private
Founded yearint
2005
Descriptiontext

MIG Fonds is a Munich-based German venture capital fund manager established in 2005 that operates a series of closed-end private placement funds (MIG 1 through MIG 18) investing in early- and growth-stage technology companies. Sponsorship of the funds is structured across three affiliated entities: HMW Emissionshaus AG acts as the fund initiator/issuer and is responsible for the prospectus, MIG Capital AG serves as the exclusive investment manager (company-builder) selecting and supporting portfolio companies, and MIG Beteiligungstreuhand GmbH is the contractual counterparty for investors. Across 18 vintages, MIG has raised approximately €1.3 billion in committed capital from individual retail investors, family offices, and professional VCs, generating 17 trade-sale exits and 4 IPOs (BioNTech, immatics, NFON, IQM via SPAC).

Portfolio focus spans life sciences (biotech, microbiome, neuroscience, immunotherapy, regenerative materials), quantum computing, AI/robotics hardware, space technology, industrial biotech, and advanced semiconductors — sectors MIG describes as the key industries of the 21st century. Notable exits include BioNTech (NASDAQ IPO October 2019, ~€763.8M proceeds to MIG), Siltectra (sold to Infineon 2018, €91.43M), and GANYMED (sold to Astellas 2016, €59.9M). Active 2023–2026 deployments include mbiomics, HawkCell, Look Up, Innatera, SciRhom, NcodiN, Inbolt, and TIBEAY.

Commercial model is a standard two-and-twenty VC fund structure with two revenue streams: annual management fees on committed capital (subscription/recurring) covering fund administration, deal sourcing, and portfolio management, and carried interest from successful exits. Distribution is bank-independent and stock-exchange-independent (banken- und börsenunabhängig): HMW Fundraising GmbH coordinates sales; the hmw.kdportal.de investor portal enables direct subscription by qualified investors in Germany, Austria and Switzerland; HMW Emissionshaus AG issues the prospectus and operates mig-fonds.de as the primary information platform. Customer segments are (1) individual retail investors, (2) family offices and professional VCs as co-investors, and (3) portfolio-company startups. The firm employs 11–50 people across the affiliated entities and is led by named partners and principals of MIG Capital AG including Andreas Kastenbauer, Dr. Søren Hein (now COO/Deputy CEO of IQM Quantum Computers), Frederick Michna, Christina Vogt-Sasse, Dr. Fei Tian, Matthias Guth, and Dr. Oliver Kahl.

Short descriptiontext

MIG Fonds is a Munich-based German venture capital fund manager established in 2005, operating 18 closed-end VC funds with ~€1.3 billion in committed capital that invest in early- and growth-stage technology companies across life sciences, quantum computing, AI/robotics, space tech, and deep tech, distributed directly to retail and family-office investors via the HMW platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMünchen, Germany
HQ citystring
München
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital funds, private equity investing, deep tech investment, life sciences venture, growth capital management
Industry3 codes
PRIMARYFSANAAAL
Venture Debt Providers
SECONDARYFSAEALAC
Venture Capital Fundraising Placement
Financial & Insurance/Financial Advisory, Brokerage & Intermediation/Placement Agents & Capital Raising Intermediation
SECONDARYFSAAABAI
Alternative Investments for Private Wealth (Hedge Funds, PE/VC Access, Private Credit)
Financial & Insurance/Asset & Wealth Management/Private Banking & HNW/UHNW Wealth Management
NAICS code3 codes
  • Funds, Trusts, and Other Financial Vehicles525
  • Other Financial Vehicles52599
  • Other Financial Investment Activities5239
SIC code2 codes
  • Investment Advice6282
  • Investors, Nec6799
Product category
Venture Capital Fund Management
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeSubscription Recurring
Description

MIG Fonds generates revenue through annual management fees charged on committed capital from investors. These fees cover fund administration, deal sourcing, portfolio management, and reporting.

mig-fonds.de
2Carried Interest (Performance Fees)
TypeTransaction Fee
Description

Fund managers earn carried interest from successful exits when portfolio companies are profitably sold, aligning manager and investor interests. Exit examples include Hemovent (25.5M EUR proceeds), Siltectra (91.43M EUR to Infineon), and GANYMED (59.9M EUR to Astellas).

mig-fonds.de
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1MIG 18
Description

The latest MIG fund, currently in placement, investing in deep tech and innovative technology companies.

mig-fonds.de
+2 more records
Core offering1 text field

MIG Fonds raises and manages a series of closed-end venture capital private placement funds (MIG 1 through MIG 18) that invest equity capital in young, innovative, unlisted technology companies. Private and institutional investors subscribe to the funds directly through MIG's bank- and stock-exchange-independent platform; returns are generated from profitable trade-sale exits and IPOs of the portfolio companies, with 17 exits and 4 IPOs historically achieved across approximately €1.3 billion of committed capital.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 17 successful exits generating distributions to investors (e.g., Siltectra to Infineon at 91.43M EUR from 12.73M EUR investment; GANYMED to Astellas at 59.9M EUR from 13.97M EUR investment)
+3 more records
Product overview1 text field

MIG Fonds is a German venture capital firm offering a series of 18 investment funds (MIG 1 through MIG 18) managed by MIG Capital AG. The funds invest in innovative technology companies across sectors including life sciences/biotech, AI and computing, MedTech, quantum technology, industrial technology, and SpaceTech. MIG 18 is the current fund in placement, building on the track record of 17 prior fully-placed funds that have produced 17 exits, 4 IPOs, and €1.3 billion in committed capital.

Product and service2 records
1MIG 18
CategoryVenture Capital Fund
Description

The latest MIG venture capital fund, currently in placement, investing in deep-tech and innovative technology companies across sectors including life sciences, AI, MedTech, and SpaceTech. Targeted at qualified private and institutional investors who subscribe directly via the MIG-18 platform.

2MIG Fonds (Fund Series 1–17)
CategoryVenture Capital Fund
Description

Series of 17 prior MIG venture capital funds, fully placed, that invested in innovative technology companies across life sciences, AI/robotics, quantum computing, MedTech, and industrial technology. These prior vintages generated 17 exits (including Hemovent, Siltectra, GANYMED, SuppreMol, BRAIN, corImmun, IdentTechnology, etkon, Sunhill, immatics, NFON, BioNTech) and 4 IPOs (BioNTech NASDAQ 2019, immatics NASDAQ 2020, NFON 2019, IQM via SPAC 2025/2026).

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

HMW Fundraising GmbH (Münchener Str. 52, 82049 Pullach im Isartal) is the sales coordinator for MIG Fonds. They operate mig-18.de and facilitate the subscription process, directing investors to the investor portal. They coordinate investor communications but are not the contractual counterparty.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

HMW Emissionshaus AG is the initiator and issuer of MIG Fonds, responsible for the fund prospectus (Verkaufsprospekt). They operate mig-fonds.de as the primary information website and are responsible for fund structuring and regulatory compliance documentation. Together with MIG Capital AG and HMW Fundraising GmbH, they form the integrated platform for MIG Fonds operations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MIG Capital AG operates as the exclusive company-builder and fund manager for MIG Fonds. The company-builder team provides entrepreneurially experienced, technology-oriented management to select, support, and develop portfolio companies with a focus on sustainable value creation and profitable exits.

Strategic tierCoreTypeOthers
Description

MIG Beteiligungstreuhand GmbH (Ismaninger Straße 102, 81675 München) is the contractual counterparty for investors in MIG Fonds and operates the investor portal on hmw.kdportal.de. They manage investor relations, subscription processing, and fund administration.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

European VC firm with multiple funds investing in early-stage technology companies. Comparable to MIG Fonds in fund-of-funds structure and European tech focus, though Creandum is more institutional-only and earlier-stage focused.

TypeDirect peer
Description

German online VC platform enabling retail investors to participate in venture capital rounds. Direct competitor to MIG Fonds' retail-facing distribution model and similarly targets German HNW/retail investors seeking VC exposure.

TypeBroad incumbent
Description

One of Europe's largest and most established VC firms with multiple funds across stages. Comparable to MIG Fonds in European technology focus and German presence, though Earlybird serves more institutional LPs and lacks MIG's retail distribution angle.

TypeDirect peer
Description

German crowd-investing platform for startup equity, closely comparable to MIG Fonds' bank-independent retail VC distribution. Both serve German retail investors seeking direct exposure to private technology companies.

TypeDirect peer
Description

Munich-based regional VC firm co-investing with MIG Fonds in Bavarian startups (e.g., mbiomics Series A). Both focus on German technology companies with Bayern Kapital providing regional public-fund backing.

TypeBroad incumbent
Description

Pan-European fund-of-funds investor and VC enabler. As a major LP and co-investor in many European VC managers including those similar to MIG, EIF represents the institutional capital base against which MIG competes for deal flow and LP relationships.

TypeBroad incumbent
Description

European VC firm with multiple funds investing in technology and life sciences companies. Comparable to MIG Fonds in deep-tech and life sciences focus, with similar fund vintage structure serving institutional LPs.

8Y Combinator (YC)
TypeEmerging player
Description

Global startup accelerator with growing European presence via YC Continuity. Comparable to MIG Fonds in early-stage tech focus and 20+ year track record, though YC uses an accelerator model and primarily serves institutional/strategic LPs rather than retail.

TypeDirect peer
Description

Germany's leading seed-stage VC backed by public and private investors, with €1.4B+ raised across multiple funds. Comparable to MIG Fonds in German deep-tech focus, though HTGF concentrates on earlier seed stages and has broader public backing.

TypeRegional player
Description

European life sciences-focused VC firm with multiple funds. Comparable to MIG Fonds' life sciences exposure (BioNTech, GANYMED, iOmx, TIBEAY) and similar fund vintage approach, though Forbion specializes exclusively in biotech/healthcare.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment11 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MIG Fonds

Venture Capital Fund Managementmig-fonds.de

MIG Fonds is a Munich-based German venture capital fund manager established in 2005, operating 18 closed-end VC funds with ~€1.3 billion in committed capital that invest in early- and growth-stage technology companies across life sciences, quantum computing, AI/robotics, space tech, and deep tech, distributed directly to retail and family-office investors via the HMW platform.

What MIG Fonds does

MIG Fonds is a Munich-based German venture capital fund manager established in 2005 that operates a series of closed-end private placement funds (MIG 1 through MIG 18) investing in early- and growth-stage technology companies. Sponsorship of the funds is structured across three affiliated entities: HMW Emissionshaus AG acts as the fund initiator/issuer and is responsible for the prospectus, MIG Capital AG serves as the exclusive investment manager (company-builder) selecting and supporting portfolio companies, and MIG Beteiligungstreuhand GmbH is the contractual counterparty for investors. Across 18 vintages, MIG has raised approximately €1.3 billion in committed capital from individual retail investors, family offices, and professional VCs, generating 17 trade-sale exits and 4 IPOs (BioNTech, immatics, NFON, IQM via SPAC).

Portfolio focus spans life sciences (biotech, microbiome, neuroscience, immunotherapy, regenerative materials), quantum computing, AI/robotics hardware, space technology, industrial biotech, and advanced semiconductors — sectors MIG describes as the key industries of the 21st century. Notable exits include BioNTech (NASDAQ IPO October 2019, ~€763.8M proceeds to MIG), Siltectra (sold to Infineon 2018, €91.43M), and GANYMED (sold to Astellas 2016, €59.9M). Active 2023–2026 deployments include mbiomics, HawkCell, Look Up, Innatera, SciRhom, NcodiN, Inbolt, and TIBEAY.

Commercial model is a standard two-and-twenty VC fund structure with two revenue streams: annual management fees on committed capital (subscription/recurring) covering fund administration, deal sourcing, and portfolio management, and carried interest from successful exits. Distribution is bank-independent and stock-exchange-independent (banken- und börsenunabhängig): HMW Fundraising GmbH coordinates sales; the hmw.kdportal.de investor portal enables direct subscription by qualified investors in Germany, Austria and Switzerland; HMW Emissionshaus AG issues the prospectus and operates mig-fonds.de as the primary information platform. Customer segments are (1) individual retail investors, (2) family offices and professional VCs as co-investors, and (3) portfolio-company startups. The firm employs 11–50 people across the affiliated entities and is led by named partners and principals of MIG Capital AG including Andreas Kastenbauer, Dr. Søren Hein (now COO/Deputy CEO of IQM Quantum Computers), Frederick Michna, Christina Vogt-Sasse, Dr. Fei Tian, Matthias Guth, and Dr. Oliver Kahl.

MIG Fonds firmographics

Firmographics
Name
MIG Fonds
Legal name
MIG Beteiligungstreuhand GmbH
Website
https://mig-fonds.de
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
MIG Fonds is a Munich-based German venture capital fund manager established in 2005, operating 18 closed-end VC funds with ~€1.3 billion in committed capital that invest in early- and growth-stage technology companies across life sciences, quantum computing, AI/robotics, space tech, and deep tech, distributed directly to retail and family-office investors via the HMW platform.
Ownership category
akta.pro rank

MIG Fonds industry classification

Industry
Product category
Venture Capital Fund Management
NAICS
Funds, Trusts, and Other Financial Vehicles (525), Other Financial Vehicles (52599), Other Financial Investment Activities (5239)
SIC
Investment Advice (6282), Investors, Nec (6799)
akta.pro industry
PRIMARYFSANAAAL
Venture Debt Providers
SECONDARYFSAEALAC
Venture Capital Fundraising Placement
Financial & Insurance/Financial Advisory, Brokerage & Intermediation/Placement Agents & Capital Raising Intermediation
SECONDARYFSAAABAI
Alternative Investments for Private Wealth (Hedge Funds, PE/VC Access, Private Credit)
Financial & Insurance/Asset & Wealth Management/Private Banking & HNW/UHNW Wealth Management

Keywords

  • Venture capital funds
  • Private equity investing
  • Deep tech investment
  • Life sciences venture
  • Growth capital management

Where MIG Fonds is headquartered

Location

Headquarters

HQ city
München
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

MIG Fonds business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Management Fees: MIG Fonds generates revenue through annual management fees charged on committed capital from investors. These fees cover fund administration, deal sourcing, portfolio management, and reporting.
  2. Carried Interest (Performance Fees): Fund managers earn carried interest from successful exits when portfolio companies are profitably sold, aligning manager and investor interests. Exit examples include Hemovent (25.5M EUR proceeds), Siltectra (91.43M EUR to Infineon), and GANYMED (59.9M EUR to Astellas).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

MIG Fonds product offering

Product offering

Core offering

MIG Fonds raises and manages a series of closed-end venture capital private placement funds (MIG 1 through MIG 18) that invest equity capital in young, innovative, unlisted technology companies. Private and institutional investors subscribe to the funds directly through MIG's bank- and stock-exchange-independent platform; returns are generated from profitable trade-sale exits and IPOs of the portfolio companies, with 17 exits and 4 IPOs historically achieved across approximately €1.3 billion of committed capital.

Product overview

MIG Fonds is a German venture capital firm offering a series of 18 investment funds (MIG 1 through MIG 18) managed by MIG Capital AG. The funds invest in innovative technology companies across sectors including life sciences/biotech, AI and computing, MedTech, quantum technology, industrial technology, and SpaceTech. MIG 18 is the current fund in placement, building on the track record of 17 prior fully-placed funds that have produced 17 exits, 4 IPOs, and €1.3 billion in committed capital.

Differentiator

Problem solved

Functional benefit

Brands

  • MIG 18: The latest MIG fund, currently in placement, investing in deep tech and innovative technology companies.
  • MIG 17
  • MIG 16

Products and services

  • MIG 18 The latest MIG venture capital fund, currently in placement, investing in deep-tech and innovative technology companies across sectors including life sciences, AI, MedTech, and SpaceTech. Targeted at qualified private and institutional investors who subscribe directly via the MIG-18 platform.
  • MIG Fonds (Fund Series 1–17) Series of 17 prior MIG venture capital funds, fully placed, that invested in innovative technology companies across life sciences, AI/robotics, quantum computing, MedTech, and industrial technology. These prior vintages generated 17 exits (including Hemovent, Siltectra, GANYMED, SuppreMol, BRAIN, corImmun, IdentTechnology, etkon, Sunhill, immatics, NFON, BioNTech) and 4 IPOs (BioNTech NASDAQ 2019, immatics NASDAQ 2020, NFON 2019, IQM via SPAC 2025/2026).

Quantifiable outcome

  • 17 successful exits generating distributions to investors (e.g., Siltectra to Infineon at 91.43M EUR from 12.73M EUR investment; GANYMED to Astellas at 59.9M EUR from 13.97M EUR investment)
  • +3 more outcomes

Companies that use MIG Fonds

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

MIG Fonds technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MIG Fonds partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • HMW Fundraising GmbHcoreChannel Partner/ Reseller/ DistributorHMW Fundraising GmbH (Münchener Str. 52, 82049 Pullach im Isartal) is the sales coordinator for MIG Fonds. They operate mig-18.de and facilitate the subscription process, directing investors to the investor portal. They coordinate investor communications but are not the contractual counterparty.
  • HMW Emissionshaus AGcoreStrategic or Co-development PartnerHMW Emissionshaus AG is the initiator and issuer of MIG Fonds, responsible for the fund prospectus (Verkaufsprospekt). They operate mig-fonds.de as the primary information website and are responsible for fund structuring and regulatory compliance documentation. Together with MIG Capital AG and HMW Fundraising GmbH, they form the integrated platform for MIG Fonds operations.
  • MIG Capital AG (Fund Manager)coreStrategic or Co-development PartnerMIG Capital AG operates as the exclusive company-builder and fund manager for MIG Fonds. The company-builder team provides entrepreneurially experienced, technology-oriented management to select, support, and develop portfolio companies with a focus on sustainable value creation and profitable exits.
  • MIG Beteiligungstreuhand GmbHcoreOthersMIG Beteiligungstreuhand GmbH (Ismaninger Straße 102, 81675 München) is the contractual counterparty for investors in MIG Fonds and operates the investor portal on hmw.kdportal.de. They manage investor relations, subscription processing, and fund administration.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

MIG Fonds competitors and assessment

Company assessment

Broad incumbents

  • Creandum: European VC firm with multiple funds investing in early-stage technology companies. Comparable to MIG Fonds in fund-of-funds structure and European tech focus, though Creandum is more institutional-only and earlier-stage focused.
  • Earlybird Venture Capital: One of Europe's largest and most established VC firms with multiple funds across stages. Comparable to MIG Fonds in European technology focus and German presence, though Earlybird serves more institutional LPs and lacks MIG's retail distribution angle.
  • European Investment Fund (EIF): Pan-European fund-of-funds investor and VC enabler. As a major LP and co-investor in many European VC managers including those similar to MIG, EIF represents the institutional capital base against which MIG competes for deal flow and LP relationships.
  • Wellington Partners: European VC firm with multiple funds investing in technology and life sciences companies. Comparable to MIG Fonds in deep-tech and life sciences focus, with similar fund vintage structure serving institutional LPs.

Direct peers

  • Companisto: German online VC platform enabling retail investors to participate in venture capital rounds. Direct competitor to MIG Fonds' retail-facing distribution model and similarly targets German HNW/retail investors seeking VC exposure.
  • seedmatch: German crowd-investing platform for startup equity, closely comparable to MIG Fonds' bank-independent retail VC distribution. Both serve German retail investors seeking direct exposure to private technology companies.
  • Bayern Kapital: Munich-based regional VC firm co-investing with MIG Fonds in Bavarian startups (e.g., mbiomics Series A). Both focus on German technology companies with Bayern Kapital providing regional public-fund backing.
  • High-Tech Gründerfonds (HTGF): Germany's leading seed-stage VC backed by public and private investors, with €1.4B+ raised across multiple funds. Comparable to MIG Fonds in German deep-tech focus, though HTGF concentrates on earlier seed stages and has broader public backing.

Emerging players

  • Y Combinator (YC): Global startup accelerator with growing European presence via YC Continuity. Comparable to MIG Fonds in early-stage tech focus and 20+ year track record, though YC uses an accelerator model and primarily serves institutional/strategic LPs rather than retail.

Regional players

  • Forbion: European life sciences-focused VC firm with multiple funds. Comparable to MIG Fonds' life sciences exposure (BioNTech, GANYMED, iOmx, TIBEAY) and similar fund vintage approach, though Forbion specializes exclusively in biotech/healthcare.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MIG Fonds social profiles

Digital presence

MIG Fonds financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MIG Fonds leadership team

Management profile

Number of profiles

Profiles7 records

MIG Fonds funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MIG Fonds M&A and investment

M&A and investment

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MIG Fonds

What does MIG Fonds do?

MIG Fonds raises and manages a series of closed-end venture capital private placement funds (MIG 1 through MIG 18) that invest equity capital in young, innovative, unlisted technology companies. Private and institutional investors subscribe to the funds directly through MIG's bank- and stock-exchange-independent platform; returns are generated from profitable trade-sale exits and IPOs of the portfolio companies, with 17 exits and 4 IPOs historically achieved across approximately €1.3 billion of committed capital.

Is MIG Fonds a public or private company?

MIG Fonds is a private company. It is classified as corporate owned and is currently operating.

When was MIG Fonds founded?

MIG Fonds was founded in 2005. It employs 1 to 10 people.

Where is MIG Fonds based?

MIG Fonds is headquartered in München, Germany, in the Europe region.

How does MIG Fonds make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest (Performance Fees).

Who are MIG Fonds's main competitors?

Broad incumbents on record are Creandum, Earlybird Venture Capital, European Investment Fund (EIF) and Wellington Partners. Direct peers are Companisto, seedmatch, Bayern Kapital and High-Tech Gründerfonds (HTGF). Y Combinator (YC) is listed as an emerging player. Forbion is listed as a regional player.

Does MIG Fonds have an API?

No public API is recorded for MIG Fonds.

What industry is MIG Fonds in?

MIG Fonds's product category is Venture Capital Fund Management. Its primary akta.pro industry code is FSANAAAL, Venture Debt Providers, with a secondary code of FSAEALAC, Venture Capital Fundraising Placement. Its NAICS code is 525 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
European BiotechnologyThe Strüngmann legacy, passed onThe Strüngmann family office launched the Strüngmann Award to recognize European biotech entrepreneurs, with a €100,000 prize. The 2026 winner is Jonathan Talbot of Mosanna and Melodia Therapeutics. The award will expand beyond Germany, Austria, and Switzerland to include more of Europe.FinSMEsmbiomics Raises $12M in Series A Fundingmbiomics, a German microbiome therapeutics company, raised $12M in Series A funding from MIG Fonds and Bayern Kapital. The funds will strengthen IND-enabling pharmacological data sets and accelerate GMP development and manufacturing. The company develops oral live bacterial therapeutics for gut microbiome modulation.Tech Funding NewsMIG Fonds and Bayern Kapital back mbiomics in €30M raise for its microbiome cancer co-therapy — TFNmbiomics completed its third Series A tranche, raising €12 million to build manufacturing facilities for complex microbial products, bringing total Series A funding to €30 million. The company's lead candidate MBX-116 is a co-therapy for second-line melanoma, with a Phase 1B study expected in 2027.VentureburnMIG Fonds and Bayern Kapital Back mbiomics €30M RaiseMbiomics closed its Series A at €30 million, with the final €12 million tranche for clinical translation and manufacturing. The lead candidate MBX-116 targets advanced melanoma as a co-therapy with immune checkpoint inhibitors, with a Phase 1b study planned for 2027.The Next WebMunich’s mbiomics closes €30M to develop live bacterial productMunich-based mbiomics closed a €30M Series A, with €12M from existing investors, to fund its lead candidate MBX-116. The company plans a Phase 1B study in second-line advanced melanoma for 2027, aiming to replace variable FMTs with a standardized live bacterial product.GlobeNewswirembiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeuticsmbiomics closed its third Series A round at €12 million, bringing the total to €30 million. The funds will support IND-enabling data and GMP development for its lead candidate MBX-116, an immune checkpoint inhibitor co-therapy for advanced melanoma. A Phase 1B study is planned for 2027.Gadgets NowQuantum Computing: Quantum computing firm IQM raises $46 millionIQM raised $46 million in a funding round led by MIG Fonds, with participation from Finland's Tesi, Tencent, and others. The firm highlighted Europe's position to lead quantum computing, noting governments and private organizations are investing to stay competitive.EU-StartupsEspoo-based IQM raises €39 million to take Europe into Quantum leadershipIQM Quantum Computers raised €39 million in Series A funding, led by MIG Fonds, bringing total funding to €71 million. The funds will accelerate hardware development, co-design application-specific quantum computers, and attract global talent. The company aims to establish sales and business development teams.Yle.fiQuantum computing startup IQM gets €11m in seed investmentEspoo-based quantum computing startup IQM has secured approximately €11.2 million in seed funding from multiple investors including US-based Matadero QED, Finnish state-owned Tesi, Helsinki-based venture capital firms Maki.vc and OpenOcean, and German investment firms MIG Fonds and Vito Venutres. The company, which develops high-speed quantum processors designed to reduce error rates limiting quantum computing, was founded on technology from Aalto University and the Technical Research Centre of Finland. IQM plans to use the investment to build infrastructure, hire talent, and expand its collaboration efforts as it aims to make quantum technology practical and commercially viable.GlobeNewswireIQM Aims to Drive Disruptive Advancements in Quantum Computing TechnologyIQM Finland Oy, a spinout from Aalto University and VTT, launched to develop high-speed quantum processors reducing error rates. It closed a $13M seed round with investors including MIG Fonds and OpenOcean. The company aims to demonstrate the fastest qubit reset and readout in the industry.